City

Frankfurt am Main (1)

Condition

Biliary Tract Cancer (CCA) (1)

Distal Cholangiocarcinoma (1)

Gall Bladder Carcinoma (1)

Hilar Cholangiocarcinoma (1)

Intrahepatic Cholangiocarcinoma (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Institut fur Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest (1)

Collaborator

Intervention

capecitabine (1)

durvalumab (1)

tremelimumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

biliary tract cancer (cca)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Biliary Tract Cancer (CCA), Intrahepatic Cholangiocarcinoma, Hilar Cholangiocarcinoma Trial in Frankfurt am Main (Durvalumab,

Recruiting

Biliary Tract Cancer (CCA)
+4 more

Durvalumab
+2 more

Frankfurt am Main, Germany

Krankenhaus Nordwest

Jun 23, 2022